News about Drug Discovery & Development

Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals

Nusano Inc. has inked a supply agreement with PharmaLogic to provide a more efficient and reliable supply of critical radioisotopes.

Drug Discovery & Development | 11/07/2024 | By Aishwarya |  222

Alembic Pharma Gets USFDA Approval for Bromfenac Ophthalmic Solution

Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (USFDA) for its generic Bromfenac Ophthalmic Solution.

Drug Discovery & Development | 11/07/2024 | By Aishwarya |  826

Lupin Gets Tentative Approval from US FDA for Empagliflozin, Linagliptin and Metformin Hydrochloride

Lupin has secured tentative approval from the United States Food and Drug Administration (US FDA)for its Abbreviated New Drug Application for Empagliflozin, Linagliptin and Metformin Hydrochloride Extended-Release (ER) Tablets.

Drug Discovery & Development | 10/07/2024 | By Aishwarya |  753

Hinova Pharma Secures FDA Fast Track Designation for HP518

Hinova Pharmaceuticals Inc. has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for HP518, an investigational drug for the treatment of Androgen-receptor positive (AR+) triple-negative breast cancer (TNBC).

Drug Discovery & Development | 08/07/2024 | By Aishwarya |  699

Alembic Pharma Gets Tentative Approval from FDA for Ivosidenib Tablets

Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivosidenib Tablets, 250 mg.

Drug Discovery & Development | 05/07/2024 | By Aishwarya |  575

Aurigene and Edity to Partner in Cell Therapy

Aurigene Pharmaceutical Services Ltd. has announced that it will provide discovery services to Edity Therapeutics in cell therapy.

Drug Discovery & Development | 03/07/2024 | By Aishwarya |  621

EMA Accepts Approval for AstraZeneca MAA for Sipavibart

AstraZeneca has announced that its Marketing Authorisation Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by the European Medicines Agency (EMA), for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised patients.

Drug Discovery & Development | 02/07/2024 | By Aishwarya |  648

Alembic Pharma Secures USFDA Tentative Approval for Bosutinib Tablets

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Bosutinib Tablets, 100 mg and 500 mg.

Drug Discovery & Development | 02/07/2024 | By Aishwarya |  893

Avantor Launches Two New J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease

Avantor, Inc. announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease.

Drug Discovery & Development | 01/07/2024 | By Manvi |  475

Alembic Pharmaceuticals Secures FDA Final Approval for Doxycycline Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Capsules, 40 mg.

Drug Discovery & Development | 29/06/2024 | By Aishwarya |  405